Study | Group | Age Mean (SD) | Sex No. of Female/Male | Weight Mean (SD) | BMI Mean (SD) | SBP Mean (SD) | FBG Mean (SD) | Duration– yr. Mean (SD) | Smoker – no. (%) |
---|---|---|---|---|---|---|---|---|---|
Brasnyo et al. | Resveratrol Placebo | 57·9(7·9) 52.5(11.1) | NA | 90.1(16.3) 105.3(16.7) | NA | 140(12) 140(17) | 7.9(2.21) 8.8(3.2) | NA | 0(10) 0(9) |
Bhatt et al. | Resveratrol Placebo | 56.67(8.91) 57.75(8.71) | 16/12 20/9 | 64.78(9.25) 63.1(9.02) | 24.66(3.57) 24.92(3.05) | 139.71(16.10) 134.51(14.61) | 11.82(3.58) 10.11(2.56) | 7.57(4.56) 6.68(4.7) | 6/28 6/29 |
Movahed et al. | Resveratrol Placebo | 52.45(6.18) 51.81(6.99) | 17/16 16/17 | 74.26(11.39) 76.60(14.27) | 27.05(3.13) 27.83(4.12) | 129.03(14.91) 129.31(15.16) | 9.76(2.76) 8.40(2.86) | 5.81(1.53) 5.39(1.36) | 7(21.9) 4.(12.9) |
Goh et al. | Resveratrol Placebo | 55.8(7.3) 56.3(6.0) | NA | 87.0(26.6) 68.3(13.7) | 29.4(6.8) 24.4(3.6) | NA | 11.8(2.9) 9.5(1.0) | 9.4(5.3) 9.6(6.3) | 1(10) 2(20) |
Tome-Carneiro et al. | Resveratrol Placebo | 63(12) 58(10) | NA | 84(11) 85(16) | 31(5.1) 32(4.5) | 130(16) 129(21) | 8.39(3) 8.22(2) | NA | 2(22) 8(36) |
Bashmakov et al. | Resveratrol Placebo | 54.0(10.1) 59.8(6.6) | 6/8 3/7 | NA | 28(3.5) 29(2.5) | NA | NA | 15(6.9) 15.2(9.5) | 3(21) 1(10) |
Thazhath et al. | Resveratrol Placebo | NA | NA | 81.1(3.7) 81.1(4.3) | NA | NA | 8.1(0.3) 8.2(0.3) | NA | NA |
Timmers et al. | Resveratrol Placebo | NA | NA | NA | NA | 138(11.8) 141(11.7) | 7.80(1.62) 7.70(1.70) | NA | NA |
Javid et al. | Resveratrol Placebo | 49.1(7.4) 50.9(8.9) | 16/5 18/4 | 73.8(10.2) 70.95(11) | 29.3(4.9) 28.3(4.8) | NA | 8.5(3.1) 9.4(3.0) | NA | NA |